Tech Company Financing Transactions
Arialys Therapeutics Funding Round
Arialys Therapeutics secured a $58 million Seed financing round on 9/13/2023. Investors included Alexandria Venture Investments, Avalon BioVentures and Catalys Pacific.
Transaction Overview
Company Name
Announced On
9/13/2023
Transaction Type
Venture Equity
Amount
$58,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance new precision medicines that specifically block pathogenic autoantibodies in the central nervous system (CNS) and expand the treatment possibilities for neuropsychiatric diseases driven by autoimmunity.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11099 NORTH TORREY PINES RD 290
LA JOLLA, CA 92037
USA
LA JOLLA, CA 92037
USA
Phone
Undisclosed
Website
Email Address
Overview
Arialys Therapeutics, a private biotech company founded by Avalon BioVentures, Catalys Pacific, and MPM Capital, is exploring scientific breakthroughs in autoimmune neurology to develop new precision medicines for autoimmune neuropsychiatric diseases. Our lead therapeutic candidate, ART5803, is being developed as a potential treatment for anti-NMDA receptor encephalitis (ANRE), a life-threatening neurological disease that causes severe psychosis. ART5803 also has potential to treat autoimmune dementia. The Arialys team has decades of experience identifying biomedical research innovations with the potential to address significant unmet medical needs and building novel therapeutics to bring to the clinic.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
Chief Medical Officer
Carrolee Barlow
Browse more venture capital transactions:
Prev: 9/13/2023: DeLorean Artificial Intelligence venture capital transaction
Next: 9/13/2023: Proven venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs